Page last updated: 2024-11-05

wb 4101 and Adenoma, Prostatic

wb 4101 has been researched along with Adenoma, Prostatic in 3 studies

N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kenny, B1
Ballard, S1
Blagg, J1
Fox, D1
Chapple, CR1
Burt, RP1
Andersson, PO1
Greengrass, P1
Wyllie, M1
Marshall, I1
Muramatsu, I1
Oshita, M1
Ohmura, T1
Kigoshi, S1
Akino, H1
Gobara, M1
Okada, K1

Reviews

1 review available for wb 4101 and Adenoma, Prostatic

ArticleYear
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlle

1997

Other Studies

2 other studies available for wb 4101 and Adenoma, Prostatic

ArticleYear
Alpha 1-adrenoceptor subtypes in the human prostate.
    British journal of urology, 1994, Volume: 74, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Aminoquinolines; Dioxanes; Dose-Response Rela

1994
Pharmacological characterization of alpha 1-adrenoceptor subtypes in the human prostate: functional and binding studies.
    British journal of urology, 1994, Volume: 74, Issue:5

    Topics: Adrenergic alpha-Antagonists; Binding, Competitive; Clonidine; Dioxanes; Dose-Response Relationship,

1994